The β-adrenergic Receptor Links Sympathetic Nerves to T cell Exhaustion
Authors
Affiliations
CD8 T cells are essential components of the immune response against viral infections and tumours, and are capable of eliminating infected and cancerous cells. However, when the antigen cannot be cleared, T cells enter a state known as exhaustion. Although it is clear that chronic antigen contributes to CD8 T cell exhaustion, less is known about how stress responses in tissues regulate T cell function. Here we show a new link between the stress-associated catecholamines and the progression of T cell exhaustion through the β-adrenergic receptor ADRB1. We identify that exhausted CD8 T cells increase ADRB1 expression and that exposure of ADRB1 T cells to catecholamines suppresses their cytokine production and proliferation. Exhausted CD8 T cells cluster around sympathetic nerves in an ADRB1-dependent manner. Ablation of β-adrenergic signalling limits the progression of T cells towards the exhausted state in chronic infection and improves effector functions when combined with immune checkpoint blockade (ICB) in melanoma. In a pancreatic cancer model resistant to ICB, β-blockers and ICB synergize to boost CD8 T cell responses and induce the development of tissue-resident memory-like T cells. Malignant disease is associated with increased catecholamine levels in patients, and our results establish a connection between the sympathetic stress response, tissue innervation and T cell exhaustion. Here, we uncover a new mechanism by which blocking β-adrenergic signalling in CD8 T cells rejuvenates anti-tumour functions.
Roussot N, Kaderbhai C, Ghiringhelli F Cancers (Basel). 2025; 17(5).
PMID: 40075753 PMC: 11898530. DOI: 10.3390/cancers17050906.
Wang Y, Yuan J, Guo K, Zhang Z, Zhu J, Arya S Front Immunol. 2025; 16:1517971.
PMID: 40066455 PMC: 11891247. DOI: 10.3389/fimmu.2025.1517971.
Molecularly engineered supramolecular fluorescent chemodosimeter for measuring epinephrine dynamics.
Zhao Y, Mei Y, Liu Z, Sun J, Tian Y Nat Commun. 2025; 16(1):1848.
PMID: 39984456 PMC: 11845772. DOI: 10.1038/s41467-025-57100-5.
Milovanovic B, Markovic N, Petrovic M, Zugic V, Ostojic M, Rankovic-Nicic L J Clin Med. 2025; 14(3).
PMID: 39941481 PMC: 11818862. DOI: 10.3390/jcm14030811.
Hijacking of the nervous system in cancer: mechanism and therapeutic targets.
Zhang Y, Liao Q, Wen X, Fan J, Yuan T, Tong X Mol Cancer. 2025; 24(1):44.
PMID: 39915765 PMC: 11800603. DOI: 10.1186/s12943-025-02246-5.